Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Lifshitz Law PLLC Announces Investigations of Altimmune, Inc. (NASDAQ:ALT), Harbor Diversified, Inc. (OTC PINK:HRBR), Sprout Social, Inc. (NASDAQ:SPT), and Inari Medical, Inc. (NASDAQ:NARI)

ALT, HRBR, SPT, NARI

NEW YORK, NY / ACCESSWIRE / May 25, 2024 / Altimmune, Inc. (NASDAQ:ALT)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose material information that: (i) Altimmune overstated the potential for pemvidutide to stand out from competing GLP-1 agonists based on the drug's efficacy and tolerability results observed in the MOMENTUM Trial; (ii) accordingly, the MOMENTUM Trial results were less significant to pemvidutide's clinical, commercial, and competitive prospects than the Company had led investors to believe; (iii) as a result of all the foregoing, the Company had overstated Altimmune's prospects for finding a strategic partner to develop pemvidutide; and (iv) the Company's public statements were materially false and misleading at all relevant times.

If you are an ALT investor and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

Harbor Diversified, Inc. (OTC PINK:HRBR)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose material information that: (i) Harbor Diversified's financial statements from May 9, 2022 to the present were misstated due to improper revenue recognition; (ii) Harbor Diversified lacked adequate internal controls; and (iii) as a result, the Company's statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all times.

If you are a HRBR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

Sprout Social, Inc. (NASDAQ:SPT)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose material information that: (i) the Company's sales and revenue growth were not indicative of the Company's growth as it transitioned to an enterprise sales cycle; (ii) that the Company faced integration challenges with its acquisition of Tagger; (iii) accordingly, the Company was "self-inducing sales headwinds;" (iv) as a result, the Company would revise fiscal year 2024 revenue guidance; and (v) the Company's positive statements about its business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

If you are a SPT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

Inari Medical, Inc. (NASDAQ:NARI)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) during the Relevant Period, the Company consistently touted Inari's "record revenue," purportedly driven by "the strength in our core VTE business," while failing to disclose that a significant portion of its expenses were used to compensate medical professionals improperly for using Inari's products; (ii) the Company had been unlawfully compensating health care professionals in violation of the federal Anti-Kickback Statute and Civil False Claims Act; and (iii) the Company had misled investors regarding business expenses in order to conceal their illicit conduct.

If you are a NARI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

ATTORNEY ADVERTISING.© 2024 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz Law PLLC
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@lifshitzlaw.com

SOURCE: Lifshitz Law PLLC



View the original press release on accesswire.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today